Analystreport

Deciphera Pharmaceuticals Inc (NASDAQ: DCPH) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $70.00 price target on the stock.

Deciphera Pharmaceuticals, Inc.  (DCPH) 
Last deciphera pharmaceuticals, inc. earnings: 3/9 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: deciphera.com/investor-relations